Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,072 | 451 | 97.9% |
| Education | $171.42 | 6 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $747.40 | 45 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $695.43 | 31 | $0 (2024) |
| PFIZER INC. | $586.54 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $571.24 | 30 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $547.71 | 45 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $531.67 | 34 | $0 (2023) |
| GlaxoSmithKline, LLC. | $524.60 | 25 | $0 (2024) |
| Amgen Inc. | $506.54 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $483.10 | 24 | $0 (2023) |
| Novo Nordisk Inc | $441.44 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,174 | 57 | AstraZeneca Pharmaceuticals LP ($166.96) |
| 2023 | $808.53 | 40 | PFIZER INC. ($112.84) |
| 2022 | $335.37 | 8 | GlaxoSmithKline, LLC. ($124.96) |
| 2021 | $106.40 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($91.89) |
| 2020 | $178.73 | 10 | Merck Sharp & Dohme Corporation ($32.80) |
| 2019 | $1,475 | 87 | Amgen Inc. ($198.45) |
| 2018 | $1,932 | 127 | PFIZER INC. ($210.20) |
| 2017 | $2,234 | 126 | Teva Pharmaceuticals USA, Inc. ($345.78) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.16 | General |
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.34 | General |
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 10/19/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: Hematology | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $103.82 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Airway Clearance Device | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Obesity | ||||||
| 09/26/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $31.10 | General |
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.52 | General |
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Gastroenterology | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,818 | 2,554 | $280,800 | $175,664 |
| 2022 | 25 | 2,121 | 2,880 | $301,907 | $187,563 |
| 2021 | 28 | 1,994 | 2,793 | $295,072 | $192,832 |
| 2020 | 25 | 2,180 | 3,043 | $323,588 | $172,059 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 278 | 444 | $88,800 | $54,571 | 61.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 329 | 725 | $84,100 | $53,636 | 63.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $29,600 | $19,647 | 66.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 165 | 165 | $12,375 | $11,868 | 95.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 89 | $8,010 | $5,397 | 67.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $4,375 | $4,288 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 139 | 140 | $4,025 | $3,944 | 98.0% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 41 | 41 | $7,216 | $2,749 | 38.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 67 | 101 | $5,050 | $2,611 | 51.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 132 | 132 | $6,600 | $2,423 | 36.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 125 | 125 | $3,125 | $2,338 | 74.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $3,025 | $2,248 | 74.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 41 | $2,460 | $1,625 | 66.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 29 | 49 | $3,871 | $1,562 | 40.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 32 | $2,080 | $1,354 | 65.1% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 37 | 45 | $3,930 | $1,334 | 33.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 18 | $1,800 | $1,043 | 58.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 75 | 76 | $5,472 | $808.52 | 14.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $556.38 | $545.22 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $1,148 | $512.38 | 44.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 12 | $661.08 | $429.44 | 65.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 26 | $783.12 | $245.72 | 31.4% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 12 | 12 | $658.32 | $224.40 | 34.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 50 | $700.00 | $170.50 | 24.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 14 | 14 | $378.00 | $86.94 | 23.0% |
About Dr. William Gilli, M.D
Dr. William Gilli, M.D is a Internal Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447257100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Gilli, M.D has received a total of $8,243 in payments from pharmaceutical and medical device companies, with $1,174 received in 2024. These payments were reported across 457 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($8,072).
As a Medicare-enrolled provider, Gilli has provided services to 8,113 Medicare beneficiaries, totaling 11,270 services with total Medicare billing of $728,117. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bakersfield, CA
- Active Since 07/07/2005
- Last Updated 10/31/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447257100
Products in Payments
- XARELTO (Drug) $430.03
- FARXIGA (Drug) $362.82
- JARDIANCE (Drug) $328.58
- SOLIQUA (Drug) $297.64
- PROAIR (Drug) $265.98
- CHANTIX (Drug) $228.90
- ELIQUIS (Drug) $218.74
- JANUVIA (Drug) $184.31
- REXULTI (Drug) $178.75
- Prolia (Biological) $175.69
- Victoza (Drug) $162.34
- XIFAXAN (Drug) $160.59
- AJOVY (Drug) $154.92
- QVAR (Drug) $151.98
- TRADJENTA (Drug) $141.54
- MYRBETRIQ (Drug) $139.90
- Tresiba (Drug) $132.19
- Myrbetriq (Drug) $124.82
- SYMBICORT (Drug) $119.54
- SOLIQUA 100/33 (Drug) $117.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bakersfield
Franco Felizarta, Md, MD
Internal Medicine — Payments: $1.3M
Dr. Soham Shah, M.d, M.D
Internal Medicine — Payments: $843,865
Dr. Hashim Kazmi, Md, MD
Internal Medicine — Payments: $122,044
Dr. Jeffrey Bacon, D.o, D.O
Internal Medicine — Payments: $108,805
Gurjit Singh, M.d, M.D
Internal Medicine — Payments: $54,630
Dr. Carlos Alvarez, Md, MD
Internal Medicine — Payments: $26,676